Keyphrases
Myeloblasts
100%
DNA Double-strand Breaks
100%
T-AML
100%
Double-strand Break Response
100%
Leukemia Patients
42%
Tumor
28%
Tumor Cells
28%
Homologous Recombination
28%
Non-homologous End Joining
28%
DNA Damage
14%
Next-generation Sequencing
14%
Genetic Modification
14%
Dysregulation
14%
Distinct Patterns
14%
Bone Marrow Cells
14%
Primary Bone
14%
Leukemogenesis
14%
Point mutation
14%
DNA Repair Genes
14%
Functional Studies
14%
Cell-intrinsic
14%
DNA Damage Response
14%
Tumor Protein p53 (TP53)
14%
Abnormal Response
14%
Chromothripsis
14%
Small Indel
14%
DNA Damage Response Genes
14%
Complex Chromosomal Aberrations
14%
Trisomy 8
14%
Medicine and Dentistry
Myeloblast
100%
Acute Myeloid Leukemia
100%
Double Stranded DNA
100%
DNA Damage Response
42%
Neoplasm
28%
Tumor Cell
28%
Non-Homologous End Joining
28%
Homologous Recombination
28%
Bone Marrow Cell
14%
Gene Mutation
14%
Leukemogenesis
14%
Point Mutation
14%
Next Generation Sequencing
14%
Chromosome Aberration
14%
Indel Mutation
14%
Chromothripsis
14%
Trisomy 8
14%
Immunology and Microbiology
Myeloid
100%
Myeloblast
100%
DNA Damage Response
42%
Tumor Cell
28%
Homologous Recombination
28%
DNA End Joining Repair
28%
Next Generation Sequencing
14%
Point Mutation
14%
Gene Mutation
14%
Bone Marrow Cell
14%
Indel Mutation
14%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Myeloblast
100%
DNA Damage Response
42%
Homologous Recombination
28%
Non-Homologous End Joining
28%
Next Generation Sequencing
14%
Gene Mutation
14%
Point Mutation
14%
Indel
14%
Chromosomal Aberration
14%
Chromothripsis
14%
Trisomy 8
14%